Prempro lawsuits: Pfizer hit with $103 million more in punitive damages

It seems that for Pfizer (PFE), the saga of Prempro is just beginning. Barely a month after the world's largest pharmaceutical company lost a case related to Wyeth's Prempro hormone replacement therapy drug and was ordered to pay punitive damages on top of earlier compensatory damages, it lost the second pending case in the matter in Philadelphia on Monday.

Initially, Pfizer was ordered in September to pay $3.75 million in compensatory damages. The punitive damages amount awarded a month later was sealed pending another verdict in a second similar case in the same courthouse. On Monday, the court revealed that Pfizer has been ordered to pay a total of $103 million in punitive damages in the two cases. The jury found the hormone drugs the two plaintiffs used for years contributed to their breast cancer. Including three other cases, so far Pfizer has been ordered to pay $165 million in punitive damages.